SCHEMBL14975674

SCHEMBL14975674

CC(C)Oc1cc[nH]c(=O)c1C(=O)N(c1ccc(F)cc1)c1cc(F)c(Oc2ccnc(Cl)c2)cc1F

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 13/20 0.38
▸ KCNQ3 O43525 1/20 0.35
▸ KCNQ2 O43526 1/20 0.35
▸ KDR P35968 3/20 0.33
▸ RIPK3 Q9Y572 3/20 0.33
▸ RIPK1 Q13546 2/20 0.33
▸ LCK P06239 1/20 0.33
▸ KIT P10721 1/20 0.33
▸ FLT3 P36888 1/20 0.33
▸ AXL P30530 5/20 0.33
▸ RIPK2 O43353 1/20 0.32
▸ TYRO3 Q06418 2/20 0.31
▸ SCN8A Q9UQD0 2/20 0.31
▸ SCN10A Q9Y5Y9 2/20 0.31
▸ MERTK Q12866 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14975426 0.90 MET (0.36) METKCNQ3KCNQ2KDRLCK
SCHEMBL14975604 0.88 AXL (0.46) METKDRRIPK3RIPK1AXL
SCHEMBL14975335 0.86 AXL (0.47) METKDRRIPK3RIPK1AXL
SCHEMBL14977826 0.84 MET (0.34) METKCNQ3KCNQ2KDRLCK
SCHEMBL16059291 0.82 MET (0.35) METKDRRIPK3RIPK1LCK
SCHEMBL14975389 0.79 MET (0.46) METKDRAXLTYRO3MERTK
SCHEMBL14975552 0.78 MET (0.44) METKDRRIPK3RIPK1AXL
SCHEMBL14975545 0.77 MET (0.47) METKDRRIPK3RIPK1AXL
SCHEMBL14975035 0.77 MET (0.42) METKDRAXLSCN8ASCN10A
SCHEMBL14975314 0.76 KDR (0.48) METKDRRIPK3RIPK1AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2782577-A2 PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES Deciphera Pharmaceuticals, LLC. (US) 2014-10-01 — — EP disclosed
WO-2013078295-A2 PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES DECIPHERA PHARMACEUTICALS, LLC (US) 2013-05-30 — — WO disclosed
Send feedback